525-47-3 Usage
General Description
5-Nitroquinoline-2-carboxylic acid is a chemical compound with the molecular formula C10H6N2O4. It is a nitroaromatic compound and contains a nitro group and a carboxylic acid functional group. 5-nitroquinoline-2-carboxylic acid is commonly used as a building block in organic synthesis and pharmaceutical research. Its nitro group makes it potentially useful for the synthesis of various heterocyclic and pharmaceutical compounds. Additionally, it has been researched for its potential as an antibacterial agent due to its ability to inhibit bacterial DNA gyrase. Its unique structure and versatile reactivity make it a valuable tool in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 525-47-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,2 and 5 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 525-47:
(5*5)+(4*2)+(3*5)+(2*4)+(1*7)=63
63 % 10 = 3
So 525-47-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H6N2O4/c13-10(14)8-5-4-6-7(11-8)2-1-3-9(6)12(15)16/h1-5H,(H,13,14)
525-47-3Relevant articles and documents
Carbapenem antibiotic compounds
-
, (2008/06/13)
The present invention relates to carbapenems and provides a compound of the formula (I) STR1 wherein: R1 is 1-hydroxyethyl, 1-fluoroethyl or hydroxymethyl; R2 is hydrogen or C1-4 alkyl; R3 is hydrogen or C1-4 alkyl; P1 is of the formula: STR2 and one or two of A,B,C,D,E,F,G and H, are nitrogen and the remainder are CH; and P is bonded to the nitrogen of the linking carbamoyl group by a carbon atom, in either ring, is substituted by the carboxy group on a carbon atom, in either ring, and is optionally further substituted, by up to three substitutents, on a carbon atom, in either ring; or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof. Processes for their preparation, intermediates in their preparation, their use as therapeutic agents and pharmaceutical compositions containing them are also described.
